Tenax Therapeutics (TENX) Cost of Revenue: 2011-2014
Historic Cost of Revenue for Tenax Therapeutics (TENX) over the last 4 years, with Apr 2014 value amounting to $129,800.
- Tenax Therapeutics' Cost of Revenue rose 9594.23% to $352,579 in Q2 2013 from the same period last year, while for Apr 2013 it was $369,158, marking a year-over-year increase of 620.27%. This contributed to the annual value of $129,800 for FY2014, which is 201.08% up from last year.
- Latest data reveals that Tenax Therapeutics reported Cost of Revenue of $129,800 as of FY2014, which was up 201.08% from $43,111 recorded in FY2013.
- In the past 5 years, Tenax Therapeutics' Cost of Revenue ranged from a high of $219,182 in FY2011 and a low of $43,111 during FY2013.
- Moreover, its 3-year median value for Cost of Revenue was $51,253 (2012), whereas its average is $74,721.
- Per our database at Business Quant, Tenax Therapeutics' Cost of Revenue plummeted by 76.62% in 2012 and then soared by 201.08% in 2014.
- Over the past 4 years, Tenax Therapeutics' Cost of Revenue (Yearly) stood at $219,182 in 2011, then slumped by 76.62% to $51,253 in 2012, then dropped by 15.89% to $43,111 in 2013, then surged by 201.08% to $129,800 in 2014.